Background To evaluate the efficacy of rituximab in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients not responding to conventional immune therapies. Methods An open-label, ...
aStroke Research Centre, Department of Brain Repair and Rehabilitation, University College London Queen Square Institute of Neurology, London, UK bComprehensive Stroke Service, National Hospital for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results